Literature DB >> 9198179

Direct thrombin inhibitors: appraisal of the antithrombotic/hemorrhagic balance.

M Verstraete1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9198179

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

1.  Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: comparison with inogatran.

Authors:  L Chi; T E Mertz; K L Rogers; N Janiczek; Y W Peng; L Saganek; R F Bousley; P L Juneau; A C Uprichard; K P Gallagher
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  Incorporation of noncoded amino acids into the N-terminal domain 1-47 of hirudin yields a highly potent and selective thrombin inhibitor.

Authors:  V De Filippis; I Russo; A Vindigni; E Di Cera; S Salmaso; A Fontana
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

3.  Antithrombotic effects of BCH 2763, a new direct thrombin inhibitor, in a canine model of venous thrombosis.

Authors:  T B McClanahan; D P Ignasiak; P Juneau; C Finkle; P D Winocour; K P Gallagher
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

4.  Effects of Intravenous Enoxaparin and Intravenous Inogatran in an Electrolytic Injury Model of Venous Thrombosis in the Dog.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-11       Impact factor: 2.300

5.  Heparin-induced thrombocytopenia in the pediatric population: a review of current literature.

Authors:  Niyati H Vakil; Abir O Kanaan; Jennifer L Donovan
Journal:  J Pediatr Pharmacol Ther       Date:  2012-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.